Significance of the overexpression of substance P and its receptor NK-1R in head and neck carcinogenesis: A systematic review and meta-analysis
MÁ González-Moles, P Ramos-García, F Esteban - Cancers, 2021 - mdpi.com
Simple Summary Head and neck cancer is the sixth most frequent type of cancer, with more
than 600,000 new cases/year, and it is responsible for around 300,000 deaths/year …
than 600,000 new cases/year, and it is responsible for around 300,000 deaths/year …
Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma
Q Shan, K Takabatake, H Omori… - International …, 2021 - spandidos-publications.com
The stromal cells in the tumor microenvironment (TME) can influence the progression of
multiple types of cancer; however, data on oral squamous cell carcinoma (OSCC) are …
multiple types of cancer; however, data on oral squamous cell carcinoma (OSCC) are …
Artificial intelligence and radiomics in head and neck cancer care: opportunities, mechanics, and challenges
LV van Dijk, CD Fuller - American Society of Clinical Oncology …, 2021 - ascopubs.org
The advent of large-scale high-performance computing has allowed the development of
machine-learning techniques in oncologic applications. Among these, there has been …
machine-learning techniques in oncologic applications. Among these, there has been …
Assessment of survival model performance following inclusion of Epstein-Barr virus DNA status in conventional TNM staging groups in Epstein-Barr virus–related …
Importance Nonanatomic prognostic factors complement the traditional anatomic staging
system and could be incorporated into the tumor-node-metastasis (TNM) framework. Several …
system and could be incorporated into the tumor-node-metastasis (TNM) framework. Several …
The ratio of preoperative serum biomarkers predicts prognosis in patients with oral squamous cell carcinoma
M Ding, Y Song, J Jing, M Tian, L Ding, Q Li… - Frontiers in …, 2021 - frontiersin.org
Background Dynamic changes in circulating immune-inflammatory cells have been
regarded as simple and convenient prognostic biomarkers in various cancers. However …
regarded as simple and convenient prognostic biomarkers in various cancers. However …
Follow‐up after oral cancer treatment—Transition to a personalized approach
M Brands, A Verbeek, S Geurts… - Journal of Oral Pathology …, 2021 - Wiley Online Library
Background Guidelines for follow‐up after oral cancer treatment are not site‐specific and
encompass the entire head and neck area rather than the oral cavity alone. This one‐size …
encompass the entire head and neck area rather than the oral cavity alone. This one‐size …
PD1 expression and correlation with its ligands in oral cancer specimens and peripheral blood
F Wehrhan, M Weber, C Baran, A Agaimy… - Journal of Cranio …, 2021 - Elsevier
Objectives This study analyzed the expression of the PD1 receptor in tumor tissue and
peripheral blood of oral squamous cell carcinoma (OSCC) patients, and correlated it with the …
peripheral blood of oral squamous cell carcinoma (OSCC) patients, and correlated it with the …
Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma
G Almadori, A Coli, E De Corso, DA Mele… - Journal of Translational …, 2021 - Springer
Background Compared to the other members of human epidermal growth factor family
receptors (HER), the role of HER3 has not been well defined in laryngeal cancer. The …
receptors (HER), the role of HER3 has not been well defined in laryngeal cancer. The …
Identification of a novel epithelial–mesenchymal transition gene signature predicting survival in patients with HNSCC
W Xin, C Zhao, L Jiang, D Pei, L Zhao… - Pathology and …, 2021 - por-journal.com
Head and neck squamous cell cancer (HNSCC) is one of the most common types of cancer
worldwide. There have been many reports suggesting that biomarkers explored via …
worldwide. There have been many reports suggesting that biomarkers explored via …
Myofascial induction therapy improves the sequelae of medical treatment in head and neck cancer survivors: a single-blind, placebo-controlled, randomized cross …
E Castro-Martín, N Galiano-Castillo… - Journal of Clinical …, 2021 - mdpi.com
Head and neck cancer (HNC) is the sixth most common cancer worldwide. Yet, less than
60% of HNC survivors receive adequate therapy for treatment-related sequelae. The …
60% of HNC survivors receive adequate therapy for treatment-related sequelae. The …